Michael S. Lopez - Concepedia

Author

Michael S. Lopez

University of California, San Francisco

Also Known As

M Lopez, M. López, M.S. Lopez, Michael S Lopez, Michael S. Lopez

Publications

670

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco Howard Hughes Medical Institute University of California, Berkeley

About

Michael S. Lopez is an author at University of California, San Francisco specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	240
2	Natural Sciences	3	3	192
3	Engineering	1	1	58
4	Biochemistry	1	1	69
5	Biomolecular Engineering	1	1	58

Michael S. Lopez

Publications

564

Citations

H-Index

Page 1

	Year	Citations
Small Molecule Recognition of c-Src via the Imatinib-Binding Conformation Arvin C. Dar, Michael S. Lopez, Kevan M. Shokat Chemistry & Biology Natural SciencesMolecular BiologySmall Molecule RecognitionConformational StudyMolecular Recognition	2008	88
A Novel Inhibitor of the LolCDE ABC Transporter Essential for Lipoprotein Trafficking in Gram-Negative Bacteria Nicholas N. Nickerson, Christine C. Jao, Yiming Xu, Antimicrobial Agents and Chemotherapy	2018	84
Host-derived fatty acids activate type VII secretion in<i>Staphylococcus aureus</i> Michael S. Lopez, Irene S. Tan, Donghong Yan, Proceedings of the National Academy of Sciences	2017	83
Optimizing Small Molecule Inhibitors of Calcium-Dependent Protein Kinase 1 to Prevent Infection by Toxoplasma gondii Sebastian Lourido, Chao Zhang, Michael S. Lopez, Journal of Medicinal Chemistry	2013	69
Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by <i>Toxoplasma gondii</i> Florentine U. Rutaganira, Jennifer Barks, Mary Savari Dhason, Journal of Medicinal Chemistry Essential EnzymePathologyChemical BiologyCellular PhysiologyMedicinal Chemistry	2017	69
Structure-Guided Inhibitor Design Expands the Scope of Analog-Sensitive Kinase Technology Chao Zhang, Michael S. Lopez, Arvin C. Dar, ACS Chemical Biology Systems BiologyEngineeringGeneral As-kinase InhibitorsDrug TargetStructure-guided Inhibitor Design	2013	58
Overcoming myelosuppression due to synthetic lethal toxicity for FLT3-targeted acute myeloid leukemia therapy Alexander A. Warkentin, Michael S. Lopez, Elisabeth A. Lasater, eLife Mixed-phenotype Acute LeukemiaPharmacotherapyTumor BiologySynthetic Lethal ToxicityMyeloid Neoplasia	2014	58
Staurosporine-Derived Inhibitors Broaden the Scope of Analog-Sensitive Kinase Technology Michael S. Lopez, Jonathan W Choy, Ulf Peters, Journal of the American Chemical Society Chemical BiologyMedicinal ChemistryDrug TargetSelective As-kinase InhibitorsNatural Sciences	2013	35
Responses to Glial Cell Line-Derived Neurotrophic Factor Change in Mice as Spermatogonial Stem Cells Form Progenitor Spermatogonia which Replicate and Give Rise to More Differentiated Progeny1 Nicole Parker, Hayley Falk, Dolly Singh, Biology of Reproduction SpermatogenesisGeneticsReproductive BiologyEpigeneticsGive Rise	2014	20

Page 1